{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-162644","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2025-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.100405+00:00","generated_at":"2026-05-18T04:29:41.891201+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Vor Bio appoints Qing Zuraw as CDO, Michel Detheux and Bo Cumbo as directors","bullets":["Resignation of director Sven (Bill) Ante Lundberg effective July 17, 2025; no disagreement cited.","Qing Zuraw appointed CDO; over 25 years in autoimmune diseases; previously led telitacicept trials at RemeGen.","Zuraw's compensation: $565k base salary, 40% target bonus, $200k signing bonus, 4.37M options, 937k RSUs.","Board expanded to 10; Michel Detheux (CEO iTeos) and Alexander Cumbo (CEO Solid Biosciences) as independent directors.","New directors receive $40k cash retainer, initial 60k options, annual 30k options per standard policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-162644","json":"https://secwatch.observer/filing/0001193125-25-162644.json","markdown":"https://secwatch.observer/filing/0001193125-25-162644.md","text":"https://secwatch.observer/filing/0001193125-25-162644.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525162644/0001193125-25-162644-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525162644/d24616d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:29:41.891201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}